EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

Liver Cancer Summit 2026

 

22-24 January, Edinburgh
Close
N. Poster
Poster title
Applicant name
Status
  5-PO8 Outcomes of barcelona clinic liver cancer 2022 guideline-discordant escalation in hepatocellular carcinoma vary by a simple performance–liver function–tumour diameter phenotype Hasan Sahin Received Received
  6-PO7 HBsAg seroclearance in chronic hepatitis B is protective against hepatocellular carcinoma and decompensation Zülal &304;stemihan Received Received
  8-PO5 Validation and Modification of AJCC 8th Staging System for Distal Bile Duct Cancer Won Ick Chang Received Received
  10-PO5 Defining efficacy and dosimetric parameters for yttrium-90 radioembolization in hepatocellular carcinoma: a single-center experience with mRECIST and LI-RADS Radiation TRA in the era of immunotherapy Maria Varela Received Received
  10-PO6 Exploring the prognostic significance of miR-1973 and snoRNAs in hepatocellular carcinoma: a preliminary study Venkata Ramana Mallela Received Received
  13-PO5 A comparison of MAFLD and MASLD diagnostic criteria in estimating the risk of de novo hepatocellular carcinoma occurrence in HCV patients achieving sustained virological response Fiammetta Di Nardo Received Received
  14-PO5 Adding Artificial Intelligence support to the Multidisciplinary Oncologic Group-guided decision process is a valid strategy to optimize tailored therapies in the hepatocellular carcinoma management Mario Romeo Received Received
  14-PO3 Distinct cardiometabolic profiles drive divergent hepatocellular carcinoma risk trajectories in advanced fibrosis-affected metabolic dysfunction–associated steatotic liver disease (MASLD) patients Mario Romeo Received Received
  15-PO3 Post-Cholecystectomy Syndrome affects Ultrasound Visualization in Non-Obese Viral-Related advanced chronic liver disease: implications of gallbladder removal for Li-RADS-based HCC surveillance Marcello Dallio Received Received
  17-PO4 Rol of PIVKA-II as a screening tool for HCC in a occidental cohort. Maria Varela Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
02:12
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

Liver Cancer Summit 2026

 

22-24 January, Edinburgh
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 22/01/2026 TO 22/01/2026
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert